advertisement
Ophthalmic Epidemiology 29
Showing records 1 to 25 | Display all abstracts in Ophthalmic Epidemiology78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Kim DH
Ophthalmic Epidemiology 2019; 26: 63-71
79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Swenor BK
Ophthalmic Epidemiology 2019; 26: 132-139
79266 Registered blindness in Kuwait - 15 years of dynamic changes
Pandova MG
Ophthalmic Epidemiology 2019; 26: 75-83
78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Lopez-Ramos A
Ophthalmic Epidemiology 2018; 25: 412-418
78923 Psychometric Properties of the Reduced Version of the Glaucoma Treatment Compliance Assessment Tool (GTCAT)
Barker GT
Ophthalmic Epidemiology 2019; 26: 55-62
78517 Identification and description of controlled clinical trials published in Spanish Ophthalmology Journals
Loezar C
Ophthalmic Epidemiology 2018; 25: 436-442
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Addis VM
Ophthalmic Epidemiology 2019; 26: 63-71
78517 Identification and description of controlled clinical trials published in Spanish Ophthalmology Journals
Madrid E
Ophthalmic Epidemiology 2018; 25: 436-442
79266 Registered blindness in Kuwait - 15 years of dynamic changes
Al-Merjan JI
Ophthalmic Epidemiology 2019; 26: 75-83
78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Gomez-Bastar PA
Ophthalmic Epidemiology 2018; 25: 412-418
78923 Psychometric Properties of the Reduced Version of the Glaucoma Treatment Compliance Assessment Tool (GTCAT)
Mansberger SL
Ophthalmic Epidemiology 2019; 26: 55-62
79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Guo X
Ophthalmic Epidemiology 2019; 26: 132-139
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Pan W
Ophthalmic Epidemiology 2019; 26: 63-71
78517 Identification and description of controlled clinical trials published in Spanish Ophthalmology Journals
Jahr C
Ophthalmic Epidemiology 2018; 25: 436-442
79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Boland MV
Ophthalmic Epidemiology 2019; 26: 132-139
78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Lansingh VC
Ophthalmic Epidemiology 2018; 25: 412-418
79266 Registered blindness in Kuwait - 15 years of dynamic changes
Sadeq NA
Ophthalmic Epidemiology 2019; 26: 75-83
78517 Identification and description of controlled clinical trials published in Spanish Ophthalmology Journals
Daviu A
Ophthalmic Epidemiology 2018; 25: 436-442
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Vanderbeek BL
Ophthalmic Epidemiology 2019; 26: 63-71
79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Goldstein JE
Ophthalmic Epidemiology 2019; 26: 132-139
78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Rodriguez-Gomez JA
Ophthalmic Epidemiology 2018; 25: 412-418
78517 Identification and description of controlled clinical trials published in Spanish Ophthalmology Journals
Ahumada H
Ophthalmic Epidemiology 2018; 25: 436-442
78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Vargas-Fragoso V
Ophthalmic Epidemiology 2018; 25: 412-418
78517 Identification and description of controlled clinical trials published in Spanish Ophthalmology Journals
Pardo-Hernandez H
Ophthalmic Epidemiology 2018; 25: 436-442
78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Soria-Arellano FA
Ophthalmic Epidemiology 2018; 25: 412-418
